Value8 NV

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0010661864
EUR
6.65
1.2 (22.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 62 Million ()

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.99%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

4.00%

stock-summary
Price to Book

0.57

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22.07%
0%
22.07%
6 Months
22.07%
0%
22.07%
1 Year
22.07%
0%
22.07%
2 Years
22.07%
0%
22.07%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Value8 NV for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.00%
EBIT Growth (5y)
21.20%
EBIT to Interest (avg)
6.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
26.92%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.48%
ROE (avg)
7.03%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.59
EV to EBIT
9.44
EV to EBITDA
9.24
EV to Capital Employed
0.56
EV to Sales
11.29
PEG Ratio
NA
Dividend Yield
11.16%
ROCE (Latest)
5.91%
ROE (Latest)
4.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Value8 NV"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 0.00% vs 500.00% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -113.59% vs 109.09% in Dec 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.20",
          "val2": "4.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.10",
          "val2": "19.00",
          "chgp": "-111.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.50",
          "chgp": "-40.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.50",
          "val2": "18.40",
          "chgp": "-113.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-536.00%",
          "val2": "4,543.70%",
          "chgp": "-507.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
4.20
4.20
Operating Profit (PBDIT) excl Other Income
-2.10
19.00
-111.05%
Interest
0.30
0.50
-40.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.50
18.40
-113.59%
Operating Profit Margin (Excl OI)
-536.00%
4,543.70%
-507.97%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2022 is 0.00% vs 500.00% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -113.59% vs 109.09% in Dec 2021

stock-summaryCompany CV
About Value8 NV stock-summary
stock-summary
Value8 NV
Pharmaceuticals & Biotechnology
Value8 NV, formerly Exendis NV, is a company based in the Netherlands, that invests in and provides services to small and medium-sized companies. The Company focuses on the long term value creation for companies in growing sectors, such as health, leisure, environment, staffing services and Internet. It offers consulting and advising services in various fields, including finance, initial public offering (IPO), investor relations and corporate governance. The Company is active primarily in the Benelux countries and in Western Europe. Value8 operates a number of subsidiaries, including Buhrs International Group BV, VGM Beheer BV, NV Dico International, Ego-Lifestyle Holding NV, Axess Group BV, Amsterdamgold.Com BV, Megapets BV, Discount4Pets.nl, Proud ICT BV (Proud Company) and HulsbosKlatt.
Company Coordinates stock-summary
Company Details
Brediusweg 33 , BUSSUM None : 1401 AB
stock-summary
Tel: 31 35 7111387
stock-summary
Registrar Details